Today's Date: October 24, 2021
Aleada Consulting Accepted Into Forbes Technology Council   •   MSD joins hands with Emirates Oncology Society and Friends of Cancer Patients for EMBRACE campaign to support Breast Cancer Awar   •   Korean War Naval Aviator Reunites With His Combat Fighter Plane   •   Foxy P's 2021 African Princes Of Comedy Tour Ramps For Tomorrow Night In The City Of Brotherly Love   •   Transformative Justice Coalition (TJC) Press Conference and March: "Justice And the First Amendment "   •   Big Brothers Big Sisters of Greater Los Angeles Honors Michael E. Kassan, Stacy Green and The Los Angeles Rams Raising Over $1,0   •   Closing Achievement Gaps for African American Young Men in San Francisco   •   Empowering Leadership in Latina Athletes (ELLA) Prepares Young Female Athletes for Success   •   Utz Brands to Report Third Quarter 2021 Financial Results on November 11, 2021   •   Redbox to Ring the NASDAQ Stock Market Opening Bell   •   Groupon Announces Date of Third Quarter 2021 Earnings Release and Conference Call   •   Ángela Aguilar And Manzanita Sol Join Forces To Give Back To Los Angeles Community For Día De Los Muertos   •   Walgreens Now Offering Moderna and Johnson & Johnson COVID-19 Vaccine Booster Shots Nationwide   •   Navy vs UC Face-Off to Start with Patriotic Team Fastrax Skydive   •   Netcapital Advisors’ Upcoming Women in Private Equity Webinar Series to Feature Keynote Speaker Gloria Feldt on the Topic   •   Cook County Treasurer Maria Pappas partners with Candace Jordan and Black Men United in a North Michigan Avenue random act of ki   •   18th Annual LeadingAge Ziegler 200 Report Ranks Not-For-Profit Senior Living Providers, Shares Outlook On Industry Trends   •   Macy’s, Inc. Board of Directors Declares Quarterly Dividend   •   Smokeball Ushers in Its Fourth-Annual Season of Giving   •   Aramark Celebrates LGBTQ+ Pride by Naming Mark Wallace the 2021 Ian Bailey Pride of Aramark Award Recipient
Bookmark and Share

Susan G. Komen® Recognizes Renowned Investigators as 2021 Recipients of Brinker Awards for Scientific Distinction

DALLAS , September 27 /Businesswire/ - Susan G. Komen®, the world’s leading breast cancer organization, recognized two widely respected and innovative breast cancer researchers this week, announcing that Carlos Caldas, M.D., FMedSci, and Judy Garber, M.D., M.P.H., have been selected as this year’s recipients of the Brinker Awards – Komen’s highest scientific honor.

The prestigious Brinker Awards for Scientific Distinction, established by Komen in 1992, recognize leading scientists for their significant contributions to our understanding of the underlying mechanisms of breast cancer (Basic Science) and advances in breast cancer care (Clinical Research), which are both essential to combating the disease.

Brinker Award for Scientific Distinction in Basic Science

This year’s Brinker Award for Scientific Distinction in Basic Science will be presented to Carlos Caldas, M.D., FMedSci, Professor of Cancer Medicine at the University of Cambridge.

Dr. Caldas is being honored for his significant contributions in the field of breast cancer genomics. His work has advanced our understanding of the DNA and RNA compositions of human breast cancers, the genomic heterogeneity of breast cancers, and the relationships of a tumor’s make up to individual outcomes and responses to breast cancer treatment. This work helped define molecular subtypes (or groups) of breast cancer and identify the genomic changes that drive tumor growth.

“We are thrilled Dr. Caldas is being recognized for his leadership and work on breast cancer functional genomics. He is an exceptional investigator, and his research has opened new horizons for breast cancer. The discoveries of Dr. Caldas and his laboratory have redefined breast cancer taxonomy, identified novel subtypes and provided critical insights to the biology of the disease,” said Komen’s Chief Scientific Advisor, Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center, Director of the Vanderbilt-Ingram Cancer Center, the B.F. Byrd Jr. Professor of Molecular Oncology.

Brinker Award for Scientific Distinction in Clinical Research

This year’s Brinker Award for Scientific Distinction in Clinical Research will be presented to Judy Garber, M.D., M.P.H., Professor of Medicine at Harvard medical School and Chief of the Division of Cancer Genetics and Prevention at the Dana Farber Cancer Institute.

Dr. Garber is being recognized for her trailblazing work and significant contributions in clinical cancer genetics that have shaped the care of people with breast cancer, their families and those at risk of breast cancer. Her research is advancing our understanding of the role of BRCA1/2 gene mutations in breast cancer and the treatment and prevention of triple-negative breast cancer and other BRCA-associated cancers.

“Dr. Garber is a true leader, both as a researcher in breast cancer genetics and as a teacher of a generation of cancer geneticists. We are delighted to recognize the accomplishments of this superb physician-scientist.” said Komen’s Chief Scientific Advisor, Dr. George Sledge, Jr. M.D., Professor of Medicine, Stanford University.

The 2021 Brinker Award winners will deliver keynote lectures at the 44th annual San Antonio Breast Cancer Symposium, which will be held both in-person and virtually on December 7-10, 2021.

Advancing breast cancer research has been a priority for Komen since opening its doors in 1982. To date, Komen has invested more than $1.1 billion in breast cancer research, making it the largest nonprofit funder of breast cancer research outside of the U.S. government.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.


STORY TAGS: United States, North America, Award, Research, Women, Philanthropy, University, Consumer, Health, Foundation, Science, Education, Oncology, Texas,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News